On Facebook Live, USC researchers Peter Kuhn, of the USC Michelson Center for Convergent Bioscience, and John Carpten, of Keck Medicine of USC’s Institute of Translational Genomics, discuss the connection between diversity and cancer research to enable personalized cancer treatment.